2901 - 2950 of 6255 Results
Title
Year
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial2021OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 27
- Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel2021OPENTitle: Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal GelJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 917End Page: 926Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212979Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212979?id=journal-of-parkinsons-disease%2Fjpd212979Citation Count: 14
- Boxing with and without Kicking Techniques for People with Parkinson’s Disease: An Explorative Pilot Randomized Controlled Trial2022OPENTitle: Boxing with and without Kicking Techniques for People with Parkinson’s Disease: An Explorative Pilot Randomized Controlled TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 8Start Page: 2585End Page: 2593Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223447Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223447?id=journal-of-parkinsons-disease%2Fjpd223447Citation Count: 14
- Restless Legs Symptoms and Periodic Leg Movements in Sleep Among Patients with Parkinson’s Disease2022OPENTitle: Restless Legs Symptoms and Periodic Leg Movements in Sleep Among Patients with Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1339End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-213100Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9156558Citation Count: 10
- Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia2022OPENTitle: Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body DementiaJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 6Start Page: 1991End Page: 2004Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213126Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213126?id=journal-of-parkinsons-disease%2Fjpd213126Citation Count: 12
- Pedunculopontine and Cuneiform Nuclei Deep Brain Stimulation for Severe Gait and Balance Disorders in Parkinson’s Disease: Interim Results from a Randomized Double-Blind Clinical Trial2021OPENTitle: Pedunculopontine and Cuneiform Nuclei Deep Brain Stimulation for Severe Gait and Balance Disorders in Parkinson’s Disease: Interim Results from a Randomized Double-Blind Clinical TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 639End Page: 653Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212793Best OA location URL: https://hal.sorbonne-universite.fr/hal-03962391Citation Count: 10
-
OPENTitle: Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged PopulationJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 967End Page: 974Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213007Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213007?id=journal-of-parkinsons-disease%2Fjpd213007Citation Count: 36
- A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study2021OPENTitle: A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 137End Page: 151Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202457Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202457?id=journal-of-parkinsons-disease%2Fjpd202457Citation Count: 28
- Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder2022OPENTitle: Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior DisorderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 6Start Page: 1921End Page: 1935Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223201Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223201?id=journal-of-parkinsons-disease%2Fjpd223201Citation Count: 15
- Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity2022OPENTitle: Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase ActivityJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 5Start Page: 1423End Page: 1447Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213128Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213128?id=journal-of-parkinsons-disease%2Fjpd213128Citation Count: 15
- Experienced Respiratory Symptoms and the Impact on Daily Life from the Perspective of People with Parkinson’s Disease: A Grounded Theory2022OPENTitle: Experienced Respiratory Symptoms and the Impact on Daily Life from the Perspective of People with Parkinson’s Disease: A Grounded TheoryJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 5Start Page: 1677End Page: 1691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213121Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213121?id=journal-of-parkinsons-disease%2Fjpd213121Citation Count: 7
-
OPENTitle: Early Parkinson’s Disease Phenotypes Tailored by Personality, Behavior, and Motor SymptomsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 5Start Page: 1665End Page: 1676Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-213070Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213070?id=journal-of-parkinsons-disease%2Fjpd213070Citation Count: 12
-
OPENTitle: Predicting Parkinson’s Disease and Its Pathology via Simple Clinical VariablesJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 341End Page: 351Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212876Best OA location URL: https://escholarship.org/content/qt8ks0w86m/qt8ks0w86m.pdfCitation Count: 12
- Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease2021OPENTitle: Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 421End Page: 436Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212892Best OA location URL: https://escholarship.org/content/qt25m1h6q7/qt25m1h6q7.pdfCitation Count: 28
- The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy2021OPENTitle: The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System AtrophyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 105End Page: 115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212877Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212877?id=journal-of-parkinsons-disease%2Fjpd212877Citation Count: 12
-
OPENTitle: Leveraging Patient Preference Information in Medical Device Clinical Trial DesignJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 57Issue #: 1Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s43441-022-00450-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s43441-022-00450-9.pdfCitation Count: 7
- Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variants2022OPENTitle: Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variantsJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41398-022-01913-1Best OA location URL: https://doi.org/10.1038/s41398-022-01913-1Citation Count: 17
- Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor function2022OPENTitle: Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor functionJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00607-8Best OA location URL: https://www.nature.com/articles/s41746-022-00607-8.pdfCitation Count: 63
- Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks2022OPENTitle: Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networksJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00674-xBest OA location URL: https://www.nature.com/articles/s41746-022-00674-x.pdfCitation Count: 26
-
OPENTitle: Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive statusJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 9Start Page: 5251End Page: 5258Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06129-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06129-1.pdfCitation Count: 1
- Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s disease2022OPENTitle: Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 44Issue #: 3Start Page: 889End Page: 895Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06457-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06457-2.pdfCitation Count: 6
- Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel2022OPENTitle: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert PanelJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 4Start Page: 1571End Page: 1582Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00388-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00388-y.pdfCitation Count: 7
- Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses2022OPENTitle: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc AnalysesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 2Start Page: 711End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00332-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00332-0.pdfCitation Count: 1
- Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries2022OPENTitle: Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 CountriesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 303End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00313-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00313-9.pdfCitation Count: 11
- Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment2022OPENTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 5
- Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment2022OPENTitle: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1319End Page: 1340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00375-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00375-3.pdfCitation Count: 23
- Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial2022OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 7
-
OPENTitle: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein ToxicityJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 1018End Page: 1036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-022-01199-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-022-01199-7.pdfCitation Count: 14
- The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England2022OPENTitle: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in EnglandJournal Name: PharmacoEconomicsPublisher: Springer Science and Business Media LLCVol: 40Issue #: 5Start Page: 559End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40273-022-01132-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40273-022-01132-y.pdfCitation Count: 10
- An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol2022OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 11
-
OPENTitle: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stressJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-20261-0Best OA location URL: https://www.nature.com/articles/s41598-022-20261-0.pdfCitation Count: 20
-
OPENTitle: Temporal order of clinical and biomarker changes in familial frontotemporal dementiaJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 10Start Page: 2194End Page: 2206Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01942-9Best OA location URL: https://www.nature.com/articles/s41591-022-01942-9.pdfCitation Count: 98
-
OPENTitle: Deep brain stimulation for obsessive–compulsive disorder: a crisis of accessJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 8Start Page: 1529End Page: 1532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01879-zCitation Count: 62
- Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signals2022OPENTitle: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signalsJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 10Start Page: 2207End Page: 2215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-022-01932-xBest OA location URL: https://www.nature.com/articles/s41591-022-01932-x.pdfCitation Count: 202
-
OPENTitle: neuromaps: structural and functional interpretation of brain mapsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 11Start Page: 1472End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41592-022-01625-wBest OA location URL: https://www.nature.com/articles/s41592-022-01625-w.pdfCitation Count: 258
- Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain2022OPENTitle: Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 4Start Page: 504End Page: 514Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-022-01031-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9245608Citation Count: 52
-
OPENTitle: Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 1Start Page: 12End Page: 26Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01221-3Best OA location URL: https://www.nature.com/articles/s41593-022-01221-3.pdfCitation Count: 242
- Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making Important2022OPENTitle: Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making ImportantJournal Name: NeuroethicsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12152-022-09496-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12152-022-09496-w.pdfCitation Count: 3
- Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRI2022OPENTitle: Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRIJournal Name: NeuroinformaticsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 4Start Page: 879End Page: 896Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12021-022-09565-8Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2021/09/20/2021.09.18.460908.full.pdfCitation Count: 5
- Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables2022OPENTitle: Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variablesJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4803End Page: 4809Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06061-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06061-4.pdfCitation Count: 21
- Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome2022OPENTitle: Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndromeJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 6Start Page: 3677End Page: 3682Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-05919-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-05919-x.pdfCitation Count: 5
- Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains2022OPENTitle: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brainsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 28Issue #: 3Start Page: 1272End Page: 1283Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-022-01875-2Best OA location URL: https://doi.org/10.1038/s41380-022-01875-2Citation Count: 42
-
OPENTitle: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brainJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00509-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-021-00509-5Citation Count: 51
- Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencing2022OPENTitle: Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencingJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 28Issue #: 3Start Page: 1327End Page: 1336Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-022-01926-8Best OA location URL: https://www.nature.com/articles/s41380-022-01926-8.pdfCitation Count: 16
-
OPENTitle: Within-host evolution of a gut pathobiont facilitates liver translocationJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 607Issue #: 7919Start Page: 563End Page: 570Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-022-04949-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9308686Citation Count: 121
- Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment2022OPENTitle: Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairmentJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 2Issue #: 10Start Page: 923End Page: 940Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-022-00290-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9833817Citation Count: 34
- Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorder2022OPENTitle: Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorderJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 27Issue #: 7Start Page: 3075End Page: 3084Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-022-01544-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9233006Citation Count: 25
-
OPENTitle: Shared mechanisms across the major psychiatric and neurodegenerative diseasesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31873-5Best OA location URL: https://escholarship.org/content/qt23t9767x/qt23t9767x.pdfCitation Count: 125
-
OPENTitle: Multimodal deep learning for Alzheimer’s disease dementia assessmentJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31037-5Best OA location URL: https://www.nature.com/articles/s41467-022-31037-5.pdfCitation Count: 180
- Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration2022OPENTitle: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-32944-3Best OA location URL: https://www.nature.com/articles/s41467-022-32944-3.pdfCitation Count: 43